Skip to main content
. 2017 Oct;8(5):816–824. doi: 10.21037/jgo.2017.07.10

Table 3. Rationales for delivery of adjuvant chemotherapy (total recipients =46).

Rationale for delivery of adjuvant chemo Yes (N) No (N)
Positive lymph nodes 36 10
Residual disease 3 43
Reason unknown/not given 3 43
Close margin 2 44
Positive margin 6 40
Angiolymphatic/perineural invasion 2 44
No response to neoadjuvant therapy 1 45

Using patient’s medical records, we retrospectively identified the indications for delivery of adjuvant chemotherapy following neoadjuvant chemoradiation followed by surgery for esophageal cancer. The most common indication was positive nodal status.